The global market for Attention Deficit Hyperactivity Disorder (ADHD) was estimated to be worth US$ 12240 million in 2023 and is forecast to a readjusted size of US$ 19380 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030.

Attention Deficit Hyperactivity Disorder (ADHD) Market

Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.

There are two main types of drugs used to treat ADHD: stimulants and non-stimulants

The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.

ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%

Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Attention Deficit Hyperactivity Disorder (ADHD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Attention Deficit Hyperactivity Disorder (ADHD).

The Attention Deficit Hyperactivity Disorder (ADHD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Attention Deficit Hyperactivity Disorder (ADHD) market comprehensively. Regional market sizes, concerning products by type, by distribution channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Attention Deficit Hyperactivity Disorder (ADHD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, distribution channel, and regions.

Market Segmentation

Scope of Attention Deficit Hyperactivity Disorder (ADHD) Market Report

Report Metric	Details
Report Name	Attention Deficit Hyperactivity Disorder (ADHD) Market
Forecasted market size in 2030	US$ 19380 million
CAGR	6.7%
Forecasted years	2024 - 2030
Segment by Type	Stimulant Non-stimulant
Segment by Distribution Channel	Hospital Pharmacy Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, CTFH
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Attention Deficit Hyperactivity Disorder (ADHD) in global and regional level.
Chapter 3: Detailed analysis of Attention Deficit Hyperactivity Disorder (ADHD) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Attention Deficit Hyperactivity Disorder (ADHD) revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Distribution Channel, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 8: Europe by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Distribution Channel and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Attention Deficit Hyperactivity Disorder (ADHD) Market size in 2030?

Ans: The Attention Deficit Hyperactivity Disorder (ADHD) Market size in 2030 will be US$ 19380 million.

Who are the main players in the Attention Deficit Hyperactivity Disorder (ADHD) Market report?

Ans: The main players in the Attention Deficit Hyperactivity Disorder (ADHD) Market are Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, CTFH

What are the Type segmentation covered in the Attention Deficit Hyperactivity Disorder (ADHD) Market report?

Ans: The Types covered in the Attention Deficit Hyperactivity Disorder (ADHD) Market report are Stimulant, Non-stimulant

1 Study Coverage

1.1 Attention Deficit Hyperactivity Disorder (ADHD) Product Introduction

1.2 Market by Type

1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Stimulant

1.2.3 Non-stimulant

1.3 Market by Distribution Channel

1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Distribution Channel (2019 VS 2023 VS 2030)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Estimates and Forecasts

2.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2023 Versus 2030

2.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Region: 2019-2024

2.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Forecast by Region (2025-2030)

2.2.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Region (2019-2030)

3 Global Attention Deficit Hyperactivity Disorder (ADHD) by Company

3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Company (2019-2024)

3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Company (2019-2024)

3.3 Competitive Landscape

3.3.1 Key Attention Deficit Hyperactivity Disorder (ADHD) Companies around the World: Ranking by Revenue

3.3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.3.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Companies Headquarters & Product Type

3.4.1 Attention Deficit Hyperactivity Disorder (ADHD) Companies Headquarters

3.4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Companies Product & Service

3.4.3 Date of International Companies Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market

3.5 Global Attention Deficit Hyperactivity Disorder (ADHD) Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 Takeda

4.1.1 Takeda Company Information

4.1.2 Takeda Description, Business Overview

4.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.1.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.1.5 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.1.6 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.1.7 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.1.8 Takeda Recent Developments

4.2 Johnson & Johnson

4.2.1 Johnson & Johnson Company Information

4.2.2 Johnson & Johnson Description, Business Overview

4.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.2.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.2.5 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.2.6 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.2.7 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.2.8 Johnson & Johnson Recent Developments

4.3 Novartis

4.3.1 Novartis Company Information

4.3.2 Novartis Description, Business Overview

4.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.3.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.3.5 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.3.6 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.3.7 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.3.8 Novartis Recent Developments

4.4 Eli Lilly

4.4.1 Eli Lilly Company Information

4.4.2 Eli Lilly Description, Business Overview

4.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.4.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.4.5 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.4.6 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.4.7 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.4.8 Eli Lilly Recent Developments

4.5 Tris Pharma

4.5.1 Tris Pharma Company Information

4.5.2 Tris Pharma Description, Business Overview

4.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.5.4 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.5.5 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.5.6 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.5.7 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.5.8 Tris Pharma Recent Developments

4.6 Neos Therapeutics

4.6.1 Neos Therapeutics Company Information

4.6.2 Neos Therapeutics Description, Business Overview

4.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.6.4 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.6.5 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.6.6 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.6.7 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.6.8 Neos Therapeutics Recent Development

4.7 Mallinckrodt

4.7.1 Mallinckrodt Company Information

4.7.2 Mallinckrodt Description, Business Overview

4.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.7.4 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.7.5 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.7.6 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.7.7 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.7.8 Mallinckrodt Recent Development

4.8 Amneal Pharmaceuticals

4.8.1 Amneal Pharmaceuticals Company Information

4.8.2 Amneal Pharmaceuticals Description, Business Overview

4.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.8.4 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.8.5 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.8.6 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.8.7 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.8.8 Amneal Pharmaceuticals Recent Development

4.9 Noven Pharmaceuticals

4.9.1 Noven Pharmaceuticals Company Information

4.9.2 Noven Pharmaceuticals Description, Business Overview

4.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.9.4 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.9.5 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.9.6 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.9.7 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.9.8 Noven Pharmaceuticals Recent Development

4.10 Purdue Parma

4.10.1 Purdue Parma Company Information

4.10.2 Purdue Parma Description, Business Overview

4.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.10.4 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.10.5 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.10.6 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.10.7 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.10.8 Purdue Parma Recent Development

4.11 CTFH

4.11.1 CTFH Company Information

4.11.2 CTFH Description, Business Overview

4.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Products Offered

4.11.4 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin (2019-2024)

4.11.5 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Product in 2023

4.11.6 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel in 2023

4.11.7 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Geographic Area in 2023

4.11.8 CTFH Recent Development

5 Breakdown Data by Type

5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)

5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Forecast by Type (2025-2030)

5.3 Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2019-2030)

6 Breakdown Data by Distribution Channel

6.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)

6.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Forecast by Distribution Channel (2025-2030)

6.3 Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2019-2030)

7 North America

7.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth 2019-2030

7.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Facts & Figures by Country (2019-2030)

7.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)

7.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Facts & Figures by Region (2019-2030)

8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)

8.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)

9 Europe

9.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth 2019-2030

9.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Facts & Figures by Country (2019-2030)

9.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)

9.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)

10 Latin America

10.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth 2019-2030

10.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market Facts & Figures by Country (2019-2030)

10.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)

10.4 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Facts & Figures by Country (2019-2030)

11.3 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024)

11.4 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Attention Deficit Hyperactivity Disorder (ADHD) Supply Chain Analysis

12.2 Attention Deficit Hyperactivity Disorder (ADHD) Key Raw Materials and Upstream Suppliers

12.3 Attention Deficit Hyperactivity Disorder (ADHD) Clients Analysis

12.4 Attention Deficit Hyperactivity Disorder (ADHD) Sales Channel and Sales Model Analysis

12.4.1 Attention Deficit Hyperactivity Disorder (ADHD) Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Attention Deficit Hyperactivity Disorder (ADHD) Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Attention Deficit Hyperactivity Disorder (ADHD) Distributors

13 Market Dynamics

13.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Trends

13.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers

13.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges

13.4 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Amneal Pharmaceuticals

Noven Pharmaceuticals

Purdue Parma

CTFH

List of Tables

Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Companies of Stimulant

Table 3. Major Companies of Non-stimulant

Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth by Distribution Channel (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (US$ Million): 2023 VS 2030

Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 8. Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Company (2019-2024) & (US$ Million)

Table 9. Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Company (2019-2024)

Table 10. Ranking of Global Top Attention Deficit Hyperactivity Disorder (ADHD) Players by Revenue (US$ Million) in 2023

Table 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 12. Global Attention Deficit Hyperactivity Disorder (ADHD) by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) as of 2023)

Table 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Companies Headquarters

Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Companies Product & Service

Table 15. Date of International Companies Enter into Attention Deficit Hyperactivity Disorder (ADHD) Market

Table 16. Global Attention Deficit Hyperactivity Disorder (ADHD) Mergers & Acquisitions, Expansion Plans

Table 17. Takeda Company Information

Table 18. Takeda Description and Business Overview

Table 19. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 20. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 21. Takeda Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 22. Takeda Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 23. Takeda Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 24. Takeda Recent Development

Table 25. Johnson & Johnson Company Information

Table 26. Johnson & Johnson Description and Business Overview

Table 27. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 28. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 29. Johnson & Johnson Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 30. Johnson & Johnson Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 31. Johnson & Johnson Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 32. Johnson & Johnson Recent Development

Table 33. Novartis Company Information

Table 34. Novartis Description and Business Overview

Table 35. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 36. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 37. Novartis Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 38. Novartis Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 39. Novartis Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 40. Novartis Recent Development

Table 41. Eli Lilly Company Information

Table 42. Eli Lilly Description and Business Overview

Table 43. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 44. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 45. Eli Lilly Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 46. Eli Lilly Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 47. Eli Lilly Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 48. Eli Lilly Recent Development

Table 49. Tris Pharma Company Information

Table 50. Tris Pharma Description and Business Overview

Table 51. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 52. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 53. Tris Pharma Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 54. Tris Pharma Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 55. Tris Pharma Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 56. Tris Pharma Recent Development

Table 57. Neos Therapeutics Company Information

Table 58. Neos Therapeutics Description and Business Overview

Table 59. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 60. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 61. Neos Therapeutics Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 62. Neos Therapeutics Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 63. Neos Therapeutics Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 64. Neos Therapeutics Recent Development

Table 65. Mallinckrodt Company Information

Table 66. Mallinckrodt Description and Business Overview

Table 67. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 68. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 69. Mallinckrodt Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 70. Mallinckrodt Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 71. Mallinckrodt Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 72. Mallinckrodt Recent Development

Table 73. Amneal Pharmaceuticals Company Information

Table 74. Amneal Pharmaceuticals Description and Business Overview

Table 75. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 76. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 77. Amneal Pharmaceuticals Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 78. Amneal Pharmaceuticals Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 79. Amneal Pharmaceuticals Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 80. Amneal Pharmaceuticals Recent Development

Table 81. Noven Pharmaceuticals Company Information

Table 82. Noven Pharmaceuticals Description and Business Overview

Table 83. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 84. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 85. Noven Pharmaceuticals Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 86. Noven Pharmaceuticals Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 87. Noven Pharmaceuticals Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 88. Noven Pharmaceuticals Recent Development

Table 89. Purdue Parma Company Information

Table 90. Purdue Parma Description and Business Overview

Table 91. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 92. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 93. Purdue Parma Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 94. Purdue Parma Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 95. Purdue Parma Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 96. Purdue Parma Recent Development

Table 97. CTFH Company Information

Table 98. CTFH Description and Business Overview

Table 99. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product

Table 100. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$ Million) and Gross Margin (2019-2024)

Table 101. CTFH Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Product in 2023

Table 102. CTFH Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Distribution Channel in 2023

Table 103. CTFH Revenue Proportion of Attention Deficit Hyperactivity Disorder (ADHD) by Geographic Area in 2023

Table 104. CTFH Recent Development

Table 105. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024) & (US$ Million)

Table 106. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 107. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 108. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Forecast by Distribution Channel (2025-2030) & (US$ Million)

Table 109. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019-2024) & (US$ Million)

Table 110. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2025-2030) & (US$ Million)

Table 111. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024) & (US$ Million)

Table 112. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 113. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Region (2019-2030) & (US$ Million)

Table 114. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Region (2025-2030) & (US$ Million)

Table 115. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024) & (US$ Million)

Table 116. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 117. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019-2024) & (US$ Million)

Table 118. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2025-2030) & (US$ Million)

Table 119. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024) & (US$ Million)

Table 120. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 121. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019-2024) & (US$ Million)

Table 122. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2025-2030) & (US$ Million)

Table 123. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024) & (US$ Million)

Table 124. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 125. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2019-2024) & (US$ Million)

Table 126. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Country (2025-2030) & (US$ Million)

Table 127. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Type (2019-2024) & (US$ Million)

Table 128. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 129. Attention Deficit Hyperactivity Disorder (ADHD) Key Raw Materials, Industry Status and Trend

Table 130. Attention Deficit Hyperactivity Disorder (ADHD) Key Raw Materials and Upstream Suppliers

Table 131. Attention Deficit Hyperactivity Disorder (ADHD) Clients Status and Trend

Table 132. Attention Deficit Hyperactivity Disorder (ADHD) Typical Clients

Table 133. Attention Deficit Hyperactivity Disorder (ADHD) Distributors

Table 134. Attention Deficit Hyperactivity Disorder (ADHD) Market Trends

Table 135. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers

Table 136. Attention Deficit Hyperactivity Disorder (ADHD) Market Challenges

Table 137. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Product Picture

Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type in 2023 & 2030

Figure 3. Stimulant Product Picture

Figure 4. Non-stimulant Product Picture

Figure 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel in 2023 & 2030

Figure 6. Hospital Pharmacy

Figure 7. Retail Pharmacy

Figure 8. Attention Deficit Hyperactivity Disorder (ADHD) Report Years Considered

Figure 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size 2019-2030 (US$ Million)

Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Region: 2023 Versus 2030

Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Region (2019-2030)

Figure 13. Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share Forecast by Type (2019-2030)

Figure 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share Forecast by Distribution Channel (2019-2030)

Figure 16. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue 2019-2030 (US$ Million)

Figure 17. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2019-2024)

Figure 18. North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2019-2024)

Figure 19. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue 2019-2030 (US$ Million)

Figure 20. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Region (2019-2030)

Figure 21. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2019-2024)

Figure 22. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2019-2024)

Figure 23. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 24. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Country (2019-2030)

Figure 25. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2019-2024)

Figure 26. Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2019-2024)

Figure 27. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 28. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Country (2019-2024)

Figure 29. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2019-2024)

Figure 30. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2019-2024)

Figure 31. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Growth Rate 2019-2030 (US$ Million)

Figure 32. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Country (2019-2030)

Figure 33. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Type (2019-2024)

Figure 34. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Distribution Channel (2019-2024)

Figure 35. Attention Deficit Hyperactivity Disorder (ADHD) Supply Chain (Upstream and Downstream Market)

Figure 36. Global Production Market Share of Attention Deficit Hyperactivity Disorder (ADHD) Raw Materials by Region in 2023

Figure 37. Attention Deficit Hyperactivity Disorder (ADHD) Distribution Channels

Figure 38. Global Attention Deficit Hyperactivity Disorder (ADHD) Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 39. Global Attention Deficit Hyperactivity Disorder (ADHD) Percentage 2019-2030: Online Sales VS Offline Sales

Figure 40. Bottom-up and Top-down Approaches for This Report

Figure 41. Data Triangulation

Figure 42. Key Executives Interviewed

Figure 43. Global Attention Deficit Hyperactivity Disorder (ADHD) Percentage 2019-2030: Online Sales VS Offline Sales

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-35C377

Wed Mar 19 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Syndrome Progressive Ataxia Weakness Disorder Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29C12714

Wed Mar 12 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Intracranial Treatment Drug Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5M14436

Wed Mar 12 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Epilepsy Detection Alert Device Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26Q12678

Wed Mar 12 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Published Date: June 2024

Report Code: QYRE-Auto-14N9172

Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

FEATURED COMPANIES

Attention Deficit Hyperactivity Disorder (ADHD) Market Size

Attention Deficit Hyperactivity Disorder (ADHD) Market

Report Scope

Scope of Attention Deficit Hyperactivity Disorder (ADHD) Market Report

Chapter Outline

FAQ for this report

What is the Attention Deficit Hyperactivity Disorder (ADHD) Market size in 2030?

Who are the main players in the Attention Deficit Hyperactivity Disorder (ADHD) Market report?

What are the Type segmentation covered in the Attention Deficit Hyperactivity Disorder (ADHD) Market report?

FEATURED COMPANIES

RELATED REPORTS

$8000

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User